Skip to main content

Advertisement

Log in

Serum TG/HDL-C level at the acute phase of ischemic stroke is associated with post-stroke cognitive impairment

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

The ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C) bears a relation with poor outcomes of acute ischemic stroke (AIS), but the impact of serum TG/HDL-C level on post-stroke cognitive impairment (PSCI) remains unknown. We conducted this prospective study to explore the association between TG/HDL-C and PSCI.

Methods

Consecutive AIS patients from the Stroke Units of our hospital were prospectively enrolled between July 1, 2020, and June 30, 2021. Blood samples were collected within 24 h after admission. Cognition function was evaluated by the Montreal Cognitive Assessment (MoCA) at 3 months after stroke. We used logistic regression analyses to explore the relationship between TG/HDL-C and PSCI, and then used a receiver operating characteristic (ROC) analysis to assess the ability of acute TG/HDL-C for predicting PSCI.

Results

A total of 227 AIS patients were recruited. Compared with patients without PSCI, those with PSCI had a higher level of TG/HDL-C at admission (P < 0.01). The multivariate logistic regression analyses showed that TG/HDL-C level was independently associated with PSCI (P < 0.01). The area under the curve of the ROC for TG/HDL-C as predictor of PSCI was 0.701 (95%CI 0.635–0.768). The optimal cutoff value of TG/HDL-C to indicate PSCI was 1.564, which gave a sensitivity of 55.2% and specificity of 80.6%.

Conclusions

Our study demonstrated that a higher level of TG/HDL-C at the acute phase of ischemic stroke predicted the presence of PSCI at 3 months after stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from Dingming Sun upon reasonable request.

References

  1. Zhou M, Wang H, Zeng X et al (2019) Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 394:1145–1158

    Article  Google Scholar 

  2. Brainin M, Tuomilehto J, Heiss WD et al (2015) Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol 22(229–238):e13–e16

    Google Scholar 

  3. Pascoe M, Ski CF, Thompson DR et al (2019) Serum cholesterol, body mass index and smoking status do not predict long-term cognitive impairment in elderly stroke patients. J Neurol Sci 406:116476

    Article  CAS  Google Scholar 

  4. Nys GM, van Zandvoort MJ, de Kort PL et al (2005) The prognostic value of domain-specific cognitive abilities in acute first-ever stroke. Neurology 64:821–827

    Article  CAS  Google Scholar 

  5. Zhang X, Bi X (2020) Post-stroke cognitive impairment: a review focusing on molecular biomarkers. J Mol Neurosci 70:8

    Google Scholar 

  6. Rothenburg LS, Herrmann N, Swardfager W et al (2010) The relationship between inflammatory markers and post stroke cognitive impairment. J Geriatr Psych Neur 23:199–205

    Article  Google Scholar 

  7. Zhu Z, Zhong C, Guo D et al (2019) Multiple biomarkers covering several pathways improve predictive ability for cognitive impairment among ischemic stroke patients with elevated blood pressure. Atherosclerosis 287:30–37

    Article  CAS  Google Scholar 

  8. Kivipelto M, Helkala EL, Hanninen T et al (2001) Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 56:1683–1689

    Article  CAS  Google Scholar 

  9. Evans RM, Emsley CL, Gao S et al (2000) Serum cholesterol, APOE genotype, and the risk of Alzheimer’s disease: a population-based study of African Americans. Neurology 54:240–242

    Article  CAS  Google Scholar 

  10. Ma C, Yin Z, Zhu P et al (2017) Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly. Mol Neurodegener 12:24

    Article  Google Scholar 

  11. Salazar MR, Carbajal HA, Espeche WG et al (2012) Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol 109:1749–1753

    Article  CAS  Google Scholar 

  12. Onat A, Can G, Kaya H et al (2010) “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 4:89–98

    Article  Google Scholar 

  13. Tsuruya K, Yoshida H, Nagata M et al (2014) Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population. Atherosclerosis 233:260–267

    Article  CAS  Google Scholar 

  14. Deng Q, Li S, Wang H et al (2018) The short-term prognostic value of the triglyceride-to-high-density lipoprotein cholesterol ratio in acute ischemic stroke. Aging Dis 9:498

    Article  Google Scholar 

  15. Deng QW, Liu YK, Zhang YQ et al (2019) Low triglyceride to high-density lipoprotein cholesterol ratio predicts hemorrhagic transformation in large atherosclerotic infarction of acute ischemic stroke. Aging (Albany NY) 11:1589–1601

    Article  CAS  Google Scholar 

  16. Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699

    Article  Google Scholar 

  17. Lees R, Selvarajah J, Fenton C et al (2014) Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke. Stroke 45:3008–3018

    Article  Google Scholar 

  18. Chen H, Du Y, Liu S et al (2019) Association between serum cholesterol levels and Alzheimer’s disease in China: a case-control study. Int J Food Sci Nutr 70:405–411

    Article  CAS  Google Scholar 

  19. He Q, Li Q, Zhao J et al (2016) Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. Lipids Health Dis 15:146–153

    Article  Google Scholar 

  20. Pokharel Y, Mouhanna F, Nambi V et al (2019) ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change. Neurology 92:e2580–e2593

    Article  CAS  Google Scholar 

  21. Svensson T, Sawada N, Mimura M et al (2019) The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up. Transl Psychiat 9:26–32

    Article  Google Scholar 

  22. Zhao B, Shang S, Li P et al (2019) The gender- and age- dependent relationships between serum lipids and cognitive impairment: a cross-sectional study in a rural area of Xi’an, China. Lipids Health Dis 18:4–14

    Article  Google Scholar 

  23. Dupuy AM, Mas E, Ritchie K et al (2001) The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer’s disease. Gerontology 47:213–218

    Article  CAS  Google Scholar 

  24. Mielke MM, Montine T, Khachaturian AS (2012) Vascular diseases: one pathway toward new conceptual models of dementia. Alzheimers Dement 8:S69–S70

    PubMed  Google Scholar 

  25. Hauser PS, Narayanaswami V, Ryan RO (2011) Apolipoprotein E: from lipid transport to neurobiology. Prog Lipid Res 50:62–74

    Article  CAS  Google Scholar 

  26. Xu H, Finkelstein DI, Adlard PA (2014) Interactions of metals and apolipoprotein E in Alzheimer’s disease. Front Aging Neurosci 6:121

    Article  Google Scholar 

  27. Marais AD (2021) Apolipoprotein E and atherosclerosis. Curr Atheroscler Rep 23:34

    Article  CAS  Google Scholar 

  28. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349–1356

    Article  CAS  Google Scholar 

  29. Yatawara C, Guevarra AC, Ng KP et al (2020) The role of cerebral microbleeds in the incidence of post-stroke dementia. J Neurol Sci 412:116736

    Article  Google Scholar 

  30. Kalaria RN (2012) Cerebrovascular disease and mechanisms of cognitive impairment. Stroke 43:2526–2534

    Article  Google Scholar 

  31. Goulay R, Mena Romo L, Hol EM et al (2020) From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-β formation. Transl Stroke Res 11:601–614

    Article  Google Scholar 

  32. Svensson T, Sawada N, Mimura M et al (2019) The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up. Transl Psychiatry 9:26

    Article  Google Scholar 

  33. Ohtani R, Nirengi S, Nakamura M et al (2018) High-density lipoprotein subclasses and mild cognitive impairment: Study of Outcome and aPolipoproteins in Dementia (STOP-Dementia)1. J Alzheimer’s Dis 66:289–296

    Article  CAS  Google Scholar 

  34. Talayero BG, Sacks FM (2011) The role of triglycerides in atherosclerosis. Curr Cardiol Rep 13:544–552

    Article  Google Scholar 

Download references

Funding

This work was supported by the Science and Technology Bureau of Yancheng (YK2019005).

Author information

Authors and Affiliations

Authors

Contributions

DMS, YG, and YQC designed the study. HHZ, YQC, JC, LL, and CXL conducted the research. YQC and HHZ wrote the paper and analyzed the data. All authors reviewed and approved the final version of the manuscript.

Corresponding authors

Correspondence to Yang Gao or Dingming Sun.

Ethics declarations

Ethical approval

This study was conducted according to the protocol approved by the Human Subjects Research Ethics Board of The First People’s Hospital of Yancheng.

Informed consent

Written informed consent was obtained from all participants.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, Y., Zhu, H., Chen, J. et al. Serum TG/HDL-C level at the acute phase of ischemic stroke is associated with post-stroke cognitive impairment. Neurol Sci 43, 5977–5984 (2022). https://doi.org/10.1007/s10072-022-06267-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-022-06267-6

Keywords

Navigation